Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Etanercept: An overview.

Ben Goffe¹, Jennifer Clay Cather

¹Department of Dermatology, University of Washington, 515 Minor Avenue, Suite 200, Seattle, WA 98104, USA. docgoffe@msn.com

Journal of the American Academy of Dermatology

|August 2, 2003

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Ixekizumab for the treatment of pediatric patients with moderate to severe plaque psoriasis.

Expert opinion on biological therapy·2021

Same author

Cannabidiol primer for healthcare professionals.

Proceedings (Baylor University. Medical Center)·2020

Same author

Patients' Perspectives on the Impact of Genital Psoriasis: A Qualitative Study.

Dermatology and therapy·2017

Same author

Psoriasis and Psoriatic Arthritis.

The Journal of clinical and aesthetic dermatology·2017

Same author

A Delphi Consensus Approach to Challenging Case Scenarios in Moderate-to-Severe Psoriasis: Part 1.

Dermatology and therapy·2012

Same author

A Delphi Consensus Approach to Challenging Case Scenarios in Moderate-to-Severe Psoriasis: Part 2.

Dermatology and therapy·2012

Same journal

Comparative Alopecia Outcomes After Copper and Hormonal Intrauterine Device Placement: A TriNetX Database Retrospective Cohort Study.

Journal of the American Academy of Dermatology·2026

Same journal

Uncovering a Dual Th17/Type 2 Transcriptomic Endotype in Psoriasis.

Journal of the American Academy of Dermatology·2026

Same journal

Dermatologic conditions associated with HIV among US adults across different racial and ethnic groups: A retrospective cohort study using TriNetX.

Journal of the American Academy of Dermatology·2026

Same journal

Ethical Considerations in Same-Day Surgical Treatment of a High-Risk, Poorly Differentiated Squamous Cell Carcinoma.

Journal of the American Academy of Dermatology·2026

Same journal

The Ethics of the Handshake in Dermatology.

Journal of the American Academy of Dermatology·2026

Same journal

Dermatology images: Hidradenitis suppurativa.

Journal of the American Academy of Dermatology·2026

See all related articles

Etanercept effectively inhibits TNF-alpha, offering a treatment for psoriatic and rheumatoid arthritis. This review covers its structure, action, and clinical trial results in psoriasis patients.

Area of Science:

Immunology
Dermatology
Pharmacology

Background:

Tumor necrosis factor-alpha (TNF-alpha) plays a key role in inflammatory conditions.
Etanercept is an established biologic therapy targeting TNF-alpha.
Current FDA approvals include psoriatic arthritis and rheumatoid arthritis.

Purpose of the Study:

To review the molecular structure of etanercept.
To elucidate the mechanism of action of etanercept as a TNF-alpha inhibitor.
To present results from clinical trials of etanercept in patients with psoriasis.

Main Methods:

Literature review of scientific publications and clinical trial data.
Analysis of etanercept's biochemical properties and biological activity.
Synthesis of findings from randomized controlled trials and observational studies.

Related Experiment Videos

Main Results:

Etanercept's dimeric structure facilitates high-affinity binding to TNF-alpha.
Inhibition of TNF-alpha by etanercept modulates inflammatory pathways relevant to psoriasis.
Clinical trials demonstrate significant efficacy and safety in treating psoriatic arthritis.

Conclusions:

Etanercept is a well-characterized TNF-alpha inhibitor with proven efficacy in psoriatic arthritis.
Its molecular properties and mechanism of action support its therapeutic role.
Further review of clinical data reinforces its value in managing psoriatic disease.